Cancer News and Research

Latest Cancer News and Research

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.

30 Aug 2011

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.

30 Aug 2011

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Radiation can make cancer cells resistant to radio- and chemotherapy. University of Oslo researchers have now figured out how resistance can be switched on and off.

30 Aug 2011

Invacare announces winners of Real Life campaign contest

Invacare Corporation, the global leader in the manufacture and distribution of home and long-term care medical products, today announced the winners of its Real Life campaign contest.

30 Aug 2011

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.

30 Aug 2011

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

30 Aug 2011

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Two scientists developed a new drug that helped pioneer the era of "personalized medicine" for cancer patients, an approach in which one-size-fits-all drugs yield to medicines customized to the genetic endowment of individual patients. Another scientist invented today's predominant technology for genetic sequencing, deciphering the genetic blueprint in the DNA that makes up the genes of living things.

30 Aug 2011

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

30 Aug 2011

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.

30 Aug 2011

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

RaySearch Laboratories: JANUARY 1 - JUNE 30, 2011. Net sales for the period totaled SEK 47.6 M.

30 Aug 2011

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

Researchers from Yale University are looking to a virus from the same family as the rabies virus to fight a form of cancer primarily found in children and young adults.

30 Aug 2011

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

The Echocardiography and Vascular Laboratory at St. Michael's Hospital has been recognized for its commitment to quality patient care and testing for heart and vascular disease.

30 Aug 2011

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer.

30 Aug 2011

Men reluctant to use sunscreen- survey

A new survey claims that less than half of men use sunscreen of at least factor 15 to protect their skin from damage.

30 Aug 2011

U-M offers transplantation for patients with bile duct cancer

Robert "Buzz" Gehle thought the itchy rash he was experiencing was a recurrence of an earlier case of shingles. But when his doctor saw he was also jaundiced, he immediately knew there was a problem with Gehle's liver.

30 Aug 2011

Ecstasy redesigned for use against blood cancer

The illicit drug ecstasy has been redesigned by researchers at the University of WA for use in treatment of blood cancers.

30 Aug 2011

Roundup: Calif. ruling may extend mental health coverage; Conn. dropping early intervention program; Alaska clinic focuses on Medicare patients

A Northern California woman's treatment for anorexia at a residential facility was medically necessary and must be covered by her healthcare plan, a federal appeals court has ruled in a case that could lead to more extensive benefits for those being treated for mental illnesses.

30 Aug 2011

Governor Perry attacked for choosing new medical treatment

Recently, the governor of Texas and presidential hopeful had a bad back treated by injecting some of his very own fat cells, after they had been cultured and treated in a laboratory. The innovative use of a patient’s own adult stem cells is showing great promise in many conditions, including damaged joints.

29 Aug 2011

Hurricane Irene affects supplies of several blood types

New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, and New Jersey, is following the emergency declarations of Mayor Bloomberg and other tri-state public officials with an emergency appeal for blood donors. The supply of several blood types, including O-negative ("universal donor") blood, which is normally maintained at the three-to-five-day inventory level, has dropped below the two-day minimum level.

29 Aug 2011

Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC

Pfizer Inc. has received FDA approval of XALKORI (crizotinib) capsules - the first and only therapy specifically for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

29 Aug 2011

Cancer News and Research

Latest Cancer News and Research

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Invacare announces winners of Real Life campaign contest

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

An advance toward using stem cells in 'regenerative medicine'

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

Men reluctant to use sunscreen- survey

U-M offers transplantation for patients with bile duct cancer

Ecstasy redesigned for use against blood cancer

Roundup: Calif. ruling may extend mental health coverage; Conn. dropping early intervention program; Alaska clinic focuses on Medicare patients

Governor Perry attacked for choosing new medical treatment

Hurricane Irene affects supplies of several blood types

Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in